IRX5 and prostate cancer: In accordance with this observation, Ellis et al. [13] proposed that the CRNDE and IRX5 genes may share the same bidirectional promoter, whereas the expression of IRX5 was shown to negatively correlate with mutant TP53 protein levels in LNCaP prostate cancer cells [21].